Cairo – Mubasher: Ibnsina Pharma logged EGP 88.9 million in net profits during the first half (H1) of 2020, a 14% year-on-year (YoY) decrease from EGP 103.19 million.
On the other hand, the company’s sales increased to EGP 9.1 billion in the six-month period ended on 30 June from EGP 7.7 billion in the year-ago period, according to a bourse disclosure on Thursday.
During the first quarter (Q1) of 2020, Ibnsina Pharma reported a 19.7% profit growth to EGP 50.27 million from EGP 41.97 million in Q1-19.
